Literature DB >> 10037460

Identification and characterization of the rat M1 muscarinic receptor promoter.

C P Klett1, T I Bonner.   

Abstract

Five subtypes of the muscarinic receptor have been cloned from both the rat and human genomes. Although all five genes have the coding sequences in a single exon, their structures 5' of the initiation codon are largely uncharacterized, except for the M4 receptor. In the brain, muscarinic receptors mediate motor and memory function by interaction with their ligand acetylcholine. In addition, the M1 muscarinic subtype has been implicated in behavior, stress-adaptive cardiovascular reflexes, and blood pressure regulation. In the current study the M1 muscarinic receptor noncoding 5'-flanking region has been identified and characterized, including the promoter and two 5' noncoding exons located approximately 13-14 kb from the coding exon. Similar to the M4 muscarinic receptor gene the M1 promoter is GC-rich, contains no TATA box, but has two potential CAAT boxes and several putative binding sites for transcription factors such as SP1 and AP-1-3. The transcription initiation site was identified by RNase protection and primer extension. Promoter activity was confirmed in transient expression assays, using luciferase reporter constructs. A 0.89-kb fragment consisting of 480 bp of the promoter, exon 1, and part of intron 1 expressed luciferase activity in two M1 receptor-expressing cell lines (CCL-107 and CCL-147), whereas a longer fragment (1.5 kb) that extends into intron 2 demonstrated significantly increased luciferase activity. The constructs exhibited responses indicating the presence of functional glucocorticoid-, acute-phase-, and heat shock-responsive elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037460     DOI: 10.1046/j.1471-4159.1999.0720900.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  7 in total

1.  The ATP7B genetic polymorphisms predict clinical outcome to platinum-based chemotherapy in lung cancer patients.

Authors:  Xiang-Ping Li; Ji-Ye Yin; Ying Wang; Hui He; Xi Li; Wei-Jing Gong; Juan Chen; Chen-Yue Qian; Yi Zheng; Fang Li; Tao Yin; Zhi-Cheng Gong; Bo-Ting Zhou; Yu Zhang; Ling Xiao; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2014-05-23

2.  Single nucleotide polymorphisms of the human M1 muscarinic acetylcholine receptor gene.

Authors:  J L Lucas; J A DeYoung; W Sadee
Journal:  AAPS PharmSci       Date:  2001

3.  The effects of hydrocortisone on rat heart muscarinic and adrenergic alpha 1, beta 1 and beta 2 receptors, propranolol-resistant binding sites and on some subsequent steps in intracellular signalling.

Authors:  Jaromír Myslivecek; Jan Rícný; Frantisek Kolár; Stanislav Tucek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-10-17       Impact factor: 3.000

4.  Benchmarking ligand-based virtual High-Throughput Screening with the PubChem database.

Authors:  Mariusz Butkiewicz; Edward W Lowe; Ralf Mueller; Jeffrey L Mendenhall; Pedro L Teixeira; C David Weaver; Jens Meiler
Journal:  Molecules       Date:  2013-01-08       Impact factor: 4.411

5.  MYOC and FOXC1 gene analysis in primary congenital glaucoma.

Authors:  Mukesh Tanwar; Manoj Kumar; Tanuj Dada; Ramanjit Sihota; Rima Dada
Journal:  Mol Vis       Date:  2010-10-08       Impact factor: 2.367

6.  WISP1 polymorphisms contribute to platinum-based chemotherapy toxicity in lung cancer patients.

Authors:  Juan Chen; Jiye Yin; Xiangping Li; Ying Wang; Yi Zheng; Chenyue Qian; Ling Xiao; Ting Zou; Zhan Wang; Junyan Liu; Wei Zhang; Honghao Zhou; Zhaoqian Liu
Journal:  Int J Mol Sci       Date:  2014-11-14       Impact factor: 5.923

7.  Evaluation of the relationship between MARCO and CD36 single-nucleotide polymorphisms and susceptibility to pulmonary tuberculosis in a Chinese Han population.

Authors:  Wenting Lao; Hui Kang; Guojiang Jin; Li Chen; Yang Chu; Jiao Sun; Bingqi Sun
Journal:  BMC Infect Dis       Date:  2017-07-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.